About: Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1997 (uk) articolo scientifico (pubblicato il 1997) (it) article scientifique publié en 1997 (fr) im Januar 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1997 (ast) artikull shkencor i botuar më 01 janar 1997 (sq) scientific article published on 01 January 1997 (en)
publication date	wds:Q73112077-768DF425-19E4-4B9A-BDA7-2E4BA9EA25F2
publication date	1997-01-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73112077-005ADD1A-2EB3-4649-ABC4-607607447E47 wds:Q73112077-04F0B831-F71C-465C-AC84-C6E02304136F wds:Q73112077-0A845276-5A20-4B16-93FF-7324353DC020 wds:Q73112077-1DA61772-C459-4602-99CA-1034B8E0526D wds:Q73112077-1FEDD750-57AC-40D3-911A-B79E2F68B580 wds:Q73112077-2A7AE386-2385-463B-A552-FD36994640BC wds:Q73112077-31844124-ECF7-4C0C-9D7D-24ADC789535A wds:Q73112077-3F925518-F7E2-426C-884E-49AF86C9D9EC wds:Q73112077-4DBE5C4C-E85C-469A-9DE7-CD0E2A1C6FE6 wds:Q73112077-4E128CA0-9C40-4901-8CDD-70897C1E59EF wds:Q73112077-529EB8EC-C865-459C-ABDA-7F63D1582A2F wds:Q73112077-53373FC5-93DB-4AD0-96EB-A0EBA6A7C289 wds:Q73112077-53E23606-7346-472A-94C1-D30DA2122D26 wds:Q73112077-5B1C1FED-DEFC-4BD6-BBC6-2E3F807F2946 wds:Q73112077-5C427034-BB96-4CD6-94B8-61F896DEA2D0 wds:Q73112077-658D7A45-6321-4B32-ADAC-403A539E4A51 wds:Q73112077-69B6993B-D6AA-4471-BDB2-41E112259BB6 wds:Q73112077-709E0088-8F48-43B9-81A1-6829D50B83F1 wds:Q73112077-7BAD3AD2-C5B9-4596-9F08-DCD30773B58E wds:Q73112077-7E948CB0-38B8-439F-B529-F4C04344C7D4 wds:Q73112077-830850BD-7E91-4060-97F6-452C8DF43F30 wds:Q73112077-83561A41-2E07-4B16-ACC1-4ACD2344EAC0 wds:Q73112077-9AA35743-8D60-4015-96EE-74738FF990AF wds:Q73112077-A19C1666-B184-43D1-9CD1-E0C7DF8BCC8D wds:Q73112077-A972844E-0A38-421C-BD1F-CED89932D8DB wds:Q73112077-B1E3D86D-795A-43F6-BDB7-AB3DEF283D63 wds:Q73112077-B272FB4D-6E8D-4A9D-A0DB-CF7109158EC5 wds:Q73112077-B3CDA8A4-7C37-4B4D-BB45-1A5A16082363 wds:Q73112077-B754CEE9-42B2-4637-9EF0-7CBFAA534F24 wds:Q73112077-C0EC7A9C-BEEC-46E9-B063-F11AA6F4A036 wds:Q73112077-C7DD7F76-9A4A-411B-B4DD-082A17365A74 wds:Q73112077-D134638F-8E90-4F53-8274-5E5372670427
cites work	Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies Antioxidant defenses and lipid peroxidation in human blood plasma Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies The pathogenesis of atherosclerosis: a perspective for the 1990s Role of oxidized low density lipoprotein in atherogenesis Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation Microsomal lipid peroxidation Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity Modified forms of low density lipoprotein and atherosclerosis Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients Antioxidant Determinations by the Use of a Stable Free Radical Continuous monitoring of in vitro oxidation of human low density lipoprotein HMG-CoA reductase inhibitors for treatment of hypercholesterolemia Separation and quantitative analysis of serum lipoproteins by means of electrophoresis on cellulose acetate Pharmacokinetics of fluvastatin and specific drug interactions Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters Cellular mechanisms for the oxidative modification of lipoproteins: implications for atherogenesis Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia Dual Effect of Lovastatin and Simvastatin on LDL-Macrophage Interaction Effects of lovastatin therapy on LDL receptor activity in circulating monocytes and on structure and composition of plasma lipoproteins Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group Double-Blind Comparison of the Efficacy and Tolerability of Simvastatin and Fluvastatin in Patients with Primary Hypercholesterolaemia Effets of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia
author name string	wds:Q73112077-335B2849-091E-4566-9E1E-4C88FE366FC6 wds:Q73112077-5A674262-9520-42C1-A368-984D7EDE647C wds:Q73112077-62B5276F-1462-454F-904E-F446EAEB2ADE wds:Q73112077-978213E6-2B8E-46C1-B70A-D84A98EB9E2F wds:Q73112077-EC9FB501-9BD6-45DD-ABD0-B676EE1AD4A4
author name string	M Aviram M Rosenblat O Hussein S Keidar S Schlezinger
rdfs:label	Reduced susceptibility of low density lipoprotein (nl) Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (en) Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (sq)
skos:prefLabel	Reduced susceptibility of low density lipoprotein (nl) Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (en) Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (sq)
name	Reduced susceptibility of low density lipoprotein (nl) Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (en) Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (sq)
title	wds:Q73112077-68AD98FA-54DC-4BD3-A17C-F78447D8E848
title	Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (en)
page(s)	wds:Q73112077-A47462FB-8E5F-498D-836B-1A77A0AEBD92
page(s)	11-18
instance of	wds:Q73112077-135BE7D9-1802-4D17-893A-0E10FC0B3306
instance of	scholarly article

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software